Fibromyalgia Year in Review: 2022

Rhematologynetwork.com
26 December 2022
https://www.rheumatologynetwork.com/view/fibromyalgia-year-in-review-2022

Researchers launch trial to treat long COVID with drug used to block effects of opioids

ABC Gold Coast
20 December 2022
https://www.abc.net.au/news/2022-12-21/long-covid-treatment-trial-drug-low-dose-naltrexone/101770626?utm_source=abc_news_web&utm_medium=content_shared&utm_campaign=abc_news_web

Are addiction drugs effective for COVID-19 sequelae? (In Japanese)

Tokyo Metropolitan Institute of Medical Sciences
06 December 2022
https://www.igakuken.or.jp/r-info/covid-19-info139.html

‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever

Pain News Network
15 November 2022
https://www.painnewsnetwork.org/stories/2022/11/15/promising-results-for-low-dose-naltrexone-as-pain-reliever

Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions

Medical Dialogues
15 November 2022
https://medicaldialogues.in/medicine/news/low-dose-naltrexone-promising-for-pain-relief-in-fibromyalgia-and-host-of-chronic-conditions-102374

Doctor Shares Alternative Spike Protein Treatments When Go-to Options Fail

Epoch Times
04 November 2022
https://archive.ph/kwlGU#selection-347.0-347.74

Low Dose Naltrexone (LDN) Increases Endorphin Levels

RecentlyHeard
30 September 2022
https://recentlyheard.com/2022/09/30/low-dose-naltrexone-ldn-increases-endorphin-levels/

When prescribed in the low dose form, LDN can help with a multitude of different ailments and issues such as anxiety, depression, inflammation, cancers, chronic pain, immune system dysfunction, and other mental health-related issues, as well.  

Covered in The LDN Book 3. Purchase The LDN Book 3 at https://www.ldnrtevents.com/collections/ldn-books and find out more!